Page last updated: 2024-08-16

technetium tc 99m sestamibi and piperidines

technetium tc 99m sestamibi has been researched along with piperidines in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cayre, A; Finat-Duclos, F; Maublant, J; Moins, N; Verrelle, P2
Atkins, F; Bhatnagar, A; Chaturvedi, PR; Harding, MW; Hawkins, MJ; Hewett, J; Peck, RA; Wang, YM; Ziessman, H1
Bates, SF; Chen, C; Figg, WD; Fojo, T; Kang, M; Robey, R1

Reviews

1 review(s) available for technetium tc 99m sestamibi and piperidines

ArticleYear
Reversal of multidrug resistance: lessons from clinical oncology.
    Novartis Foundation symposium, 2002, Volume: 243

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzazepines; Clinical Trials as Topic; Cyclosporins; Dibenzocycloheptenes; Drug Interactions; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Inhibitors; Fluorescent Dyes; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Mice; Mice, Knockout; Neoplasm Proteins; Neoplasms; Piperidines; Pyridines; Quinolines; Radionuclide Imaging; Radiopharmaceuticals; Rhodamines; Technetium Tc 99m Sestamibi; Tissue Distribution; Tumor Cells, Cultured

2002

Trials

1 trial(s) available for technetium tc 99m sestamibi and piperidines

ArticleYear
Phase I and pharmacokinetic study of the novel MDR1 and MRP1 inhibitor biricodar administered alone and in combination with doxorubicin.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Jun-15, Volume: 19, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA-Binding Proteins; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Female; Half-Life; Humans; Infusions, Intravenous; Liver; Male; Maximum Tolerated Dose; Middle Aged; Multidrug Resistance-Associated Proteins; MutS Homolog 3 Protein; Neoplasms; Piperidines; Pyridines; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tissue Distribution

2001

Other Studies

2 other study(ies) available for technetium tc 99m sestamibi and piperidines

ArticleYear
Comparison between technetium-99m-sestamibi and hydrogen-3-daunomycin myocardial cellular retention in vitro.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:11

    Topics: Animals; Animals, Newborn; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Cyclosporins; Daunorubicin; Drug Resistance, Neoplasm; Genes, MDR; Heart; In Vitro Techniques; Myocardium; Piperidines; Radionuclide Imaging; Rats; Rats, Wistar; Technetium Tc 99m Sestamibi; Triazines; Tritium; Verapamil

1997
Comparative 99mTc-sestamibi and 3H-daunomycin uptake in human carcinoma cells: relation to the MDR phenotype and effects of reversing agents.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1999, Volume: 40, Issue:4

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cyclosporins; Daunorubicin; Drug Resistance, Multiple; Humans; Piperidines; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Technetium Tc 99m Sestamibi; Triazines; Tritium; Tumor Cells, Cultured; Verapamil

1999